BB Biotech (Switzerland) Insiders

BB Biotech Management Team Effectiveness

The company has return on total asset (ROA) of 0.0453 % which means that it generated a profit of $0.0453 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0732 %, meaning that it generated $0.0732 on every $100 dollars invested by stockholders. BB Biotech's management efficiency ratios could be used to measure how well BB Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At this time, BB Biotech's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to climb to 0.07 in 2026, whereas Return On Capital Employed is likely to drop 0.04 in 2026. At this time, BB Biotech's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 2.9 B in 2026, despite the fact that Other Assets are likely to grow to (2.3 B). Common Stock Shares Outstanding is likely to climb to about 59.9 M in 2026, whereas Net Income Applicable To Common Shares is likely to drop slightly above 64.9 M in 2026. BB Biotech AG secures a total of 55.15 Million outstanding shares. Roughly 85.17 % of BB Biotech outstanding shares are held by general public with 0.07 percent owned by insiders and only 14.76 (percent) by institutions. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as BB Biotech in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of BB Biotech, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

BB Biotech Workforce Comparison

The company has Profit Margin (PM) of 0.82 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.99 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.99.

BB Biotech AG Benchmark Summation

BB Biotech Stakeholder

String symbol = request.getParameter("s");

The success or failure of an entity such as BB Biotech AG often depends on how effective the management is. BB Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BION management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BION management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in BB Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BB Biotech AG. Check BB Biotech's Beneish M Score to see the likelihood of BB Biotech's management manipulating its earnings.

When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.